Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report

INTRODUCTION: Natalizumab is a new treatment for relapsing-remitting multiple sclerosis. Because of limited experience of this treatment, medical professionals must be alert to possible side effects. CASE PRESENTATION: We present a 34-year-old Caucasian woman with relapsing-remitting multiple sclero...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatzonis, Stylianos, Siatouni, Anna
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827173/
http://dx.doi.org/10.4076/1752-1947-3-8955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827173/
http://dx.doi.org/10.4076/1752-1947-3-8955

Ejemplares similares